188 related articles for article (PubMed ID: 8927047)
21. Permolybdate and pertungstate--potent stimulators of insulin effects in rat adipocytes: mechanism of action.
Li J; Elberg G; Gefel D; Shechter Y
Biochemistry; 1995 May; 34(18):6218-25. PubMed ID: 7742327
[TBL] [Abstract][Full Text] [Related]
22. Peroxovanadium compounds as inhibitors of angiogenesis.
Doillon CJ; Faure RL; Posner BI; Savard PE
Angiogenesis; 1999; 3(4):361-9. PubMed ID: 14517416
[TBL] [Abstract][Full Text] [Related]
23. Peroxyvanadium compounds inhibit glucose-6-phosphatase activity and glucagon-stimulated hepatic glucose output in the rat in vivo.
Westergaard N; Brand CL; Lewinsky RH; Andersen HS; Carr RD; Burchell A; Lundgren K
Arch Biochem Biophys; 1999 Jun; 366(1):55-60. PubMed ID: 10334863
[TBL] [Abstract][Full Text] [Related]
24. Peroxovanadate and insulin action in adipocytes from NIDDM patients. Evidence against a primary defect in tyrosine phosphorylation.
Yu ZW; Jansson PA; Posner BI; Smith U; Eriksson JW
Diabetologia; 1997 Oct; 40(10):1197-203. PubMed ID: 9349602
[TBL] [Abstract][Full Text] [Related]
25. Organo-vanadium compounds are potent activators of the protein kinase B signaling pathway and protein tyrosine phosphorylation: mechanism of insulinomimesis.
Mehdi MZ; Srivastava AK
Arch Biochem Biophys; 2005 Aug; 440(2):158-64. PubMed ID: 16055077
[TBL] [Abstract][Full Text] [Related]
26. [Insulin-mimetic property of vanadium compounds].
Korbecki J; Baranowska-Bosiacka I; Gutowska I; Chlubek D
Postepy Biochem; 2016; 62(1):60-65. PubMed ID: 28132446
[TBL] [Abstract][Full Text] [Related]
27. Inhibition Effects of Some Bioactive Peroxovanadium Complexes on the Tyrosine Phosphatase.
Zhou XW; Chen Z; Chen QX; Ye JL; Huang PQ; Wu QY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2000; 32(2):133-138. PubMed ID: 12098789
[TBL] [Abstract][Full Text] [Related]
28. Peroxide(s) of vanadium: a novel and potent insulin-mimetic agent which activates the insulin receptor kinase.
Kadota S; Fantus IG; Deragon G; Guyda HJ; Hersh B; Posner BI
Biochem Biophys Res Commun; 1987 Aug; 147(1):259-66. PubMed ID: 3632668
[TBL] [Abstract][Full Text] [Related]
29. A peroxovanadium compound induces Xenopus oocyte maturation: inhibition by a neutralizing anti-insulin receptor antibody.
Cummings C; Zhu L; Sorisky A; Liu XJ
Dev Biol; 1996 May; 175(2):338-46. PubMed ID: 8626037
[TBL] [Abstract][Full Text] [Related]
30. Vanadate augments insulin-stimulated insulin receptor kinase activity and prolongs insulin action in rat adipocytes. Evidence for transduction of amplitude of signaling into duration of response.
Fantus IG; Ahmad F; Deragon G
Diabetes; 1994 Mar; 43(3):375-83. PubMed ID: 7508873
[TBL] [Abstract][Full Text] [Related]
31. Insulin-mimetic signalling of synthetic phosphoinositolglycans in isolated rat adipocytes.
Frick W; Bauer A; Bauer J; Wied S; Müller G
Biochem J; 1998 Nov; 336 ( Pt 1)(Pt 1):163-81. PubMed ID: 9806898
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of pervanadate stimulation and potentiation of insulin-activated glucose transport in rat adipocytes: dissociation from vanadate effect.
Shisheva A; Shechter Y
Endocrinology; 1993 Oct; 133(4):1562-8. PubMed ID: 8404595
[TBL] [Abstract][Full Text] [Related]
33. Modulation of interferon-gamma-induced macrophage activation by phosphotyrosine phosphatases inhibition. Effect on murine Leishmaniasis progression.
Olivier M; Romero-Gallo BJ; Matte C; Blanchette J; Posner BI; Tremblay MJ; Faure R
J Biol Chem; 1998 May; 273(22):13944-9. PubMed ID: 9593743
[TBL] [Abstract][Full Text] [Related]
34. Does the insulin-mimetic action of vanadate involve insulin receptor kinase?
Pugazhenthi S; Khandelwal RL
Mol Cell Biochem; 1993 Nov; 127-128():211-8. PubMed ID: 7523848
[TBL] [Abstract][Full Text] [Related]
35. In vivo effects of peroxovanadium compounds in BB rats.
Yale JF; Vigeant C; Nardolillo C; Chu Q; Yu JZ; Shaver A; Posner BI
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):181-90. PubMed ID: 8927037
[TBL] [Abstract][Full Text] [Related]
36. Insulino-mimetic and anti-diabetic effects of vanadium compounds.
Srivastava AK; Mehdi MZ
Diabet Med; 2005 Jan; 22(1):2-13. PubMed ID: 15606684
[TBL] [Abstract][Full Text] [Related]
37. Modulation of insulin action by vanadate: evidence of a role for phosphotyrosine phosphatase activity to alter cellular signaling.
Fantus IG; Deragon G; Lai R; Tang S
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):103-12. PubMed ID: 8927024
[TBL] [Abstract][Full Text] [Related]
38. Tyrosine phosphatase inhibitors, vanadate and pervanadate, stimulate glucose transport and GLUT translocation in muscle cells by a mechanism independent of phosphatidylinositol 3-kinase and protein kinase C.
Tsiani E; Bogdanovic E; Sorisky A; Nagy L; Fantus IG
Diabetes; 1998 Nov; 47(11):1676-86. PubMed ID: 9792535
[TBL] [Abstract][Full Text] [Related]
39. Transdermally delivered peroxovanadium can lower blood glucose levels in diabetic rats.
Brand RM; Hamel FG
Int J Pharm; 1999 Jun; 183(2):117-23. PubMed ID: 10361162
[TBL] [Abstract][Full Text] [Related]
40. Vanadium Compounds as PTP Inhibitors.
Irving E; Stoker AW
Molecules; 2017 Dec; 22(12):. PubMed ID: 29257048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
